ReviewActa pharmacologica Sinica2022

Current status and challenges in the drug treatment for fibrotic nonalcoholic steatohepatitis.

Yi-Wen Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.